Valneva SE (VALN) Net Income Growth (3y) (2024 - 2026)
Valneva SE (VALN) Net Income Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | 9.16% |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.57 Bn | 466.77 Bn | 1.35 Bn | 38.43% |
| 5 | Vertex Pharmaceuticals | 122.01 Bn | 114.76 Bn | 2.59 Bn | 13.80% |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | -3.84% |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn | 79.26% |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn | 47.10% |
| 10 | Valneva SE | 839.18 Mn | 719.39 Mn | 5.38 Mn | -54.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -54.37% |
| Dec 31, 2025 | 40.88% |
| Sep 30, 2025 | -29.53% |
| Jun 30, 2025 | 56.43% |
| Mar 31, 2025 | 37.74% |
| Dec 31, 2024 | 51.23% |
| Sep 30, 2024 | -27.15% |
| Jun 30, 2024 | -34.45% |
| Mar 31, 2024 | 28.61% |